Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
Fourth biggest bond ever needed new pricing approach to work -
2023 has been a slow year for Saudi Arabia's IPO market
-
In a block trade, GSK sold 2.6% of its former joint venture with Pfizer
-
After a blowout 2022, the pace of issuance in Saudi equity capital markets has slowed this year
-
Pipeline fills as foreign and domestic names prepare to print
-
Danish firm specialised in treatment for metabolic diseases issues 6.5m shares
